AdobeStock_387236807_Preview

Driving innovation across theranostics, nuclear medicine and medical imaging

Whether you are looking to develop a theranostic solution or a next-generation radiology system, we help you create nuclear medicine technologies that transform healthcare. Drawing on 40 years of medical device development experience, our in-house team of applied scientists, engineers and designers focus on simplifying complex processes, enhancing usability and ensuring your technology integrates seamlessly into clinical workflows and time-critical environments between manufacture and patient.

Get in touch to find out how we can accelerate your development, de-risk your programme and translate your technology into a commercial product.

AdobeStock_284485843

Theranostic systems

Targeted alpha therapies and theranostics are no longer “emerging” – they’re moving into deployment. The key challenge facing the industry lies in optimising the infrastructure needed to enable them, including capacity, shielding, automation and cost.

Working across user-centred design, applied science and engineering, we help you develop end-to-end theranostic systems that integrate seamlessly with imaging workflows. With a core focus on user-centred design, workflow integration and user safety, we help you deliver theranostic solutions that improve efficiency and deliver real impact.

AdobeStock_159341276_Preview

Medical imaging technology development

The clinical value of molecular imaging is widely recognised, yet it is often limited by the systems and workflows around its deployment. Working at the intersection of imaging systems, radiopharmaceuticals and clinical workflows, we help you integrate diagnostic imaging seamlessly with your therapy application. Drawing on our multidisciplinary expertise and proven track record supporting world‑leading pharmacos, we support the development of robust, regulatory‑ready imaging technologies that accelerate clinical adoption and strengthen your theranostic strategy.

Looking to create a user-centred nuclear medicine workflow?

Whether you are looking to apply automation or digitalisation to your GMP process, or develop a truly user-centred nuclear medicine workflow, get in touch to find out how we can help you bring your theranostic solution to market.

Get in touch to find out how we can help you.

Get in touch

Nuclear medicine support from production to patient

Dosimetry and drug delivery

We help you develop theranostic systems that deliver accurate, clinically meaningful dosimetry, enabling patient specific and organ level dose assessment to improve therapeutic efficacy and safety at the point of treatment.

Combining applied science, robust engineering and user‑centred design, we help you integrate dosimetry directly with your delivery system, designing workflow‑ready devices that enable reliable dose measurement, verification and traceability. Through early‑stage dose modelling, system‑level optimisation and automation, we reduce variability, manage risk and help you deliver theranostic drug delivery solutions that perform within time‑critical clinical pathways.

Clinical workflow and real world use

Nuclear medicine environments place unique demands on both technology and the people who use it. We put clinical workflow and user needs at the centre of your development, designing theranostic drug delivery solutions that fit seamlessly into existing imaging pathways and departmental practices.

Building a deep understanding of the realities of busy nuclear medicine departments, from preparation and administration through to imaging and follow up, we help ensure solutions are intuitive, efficient and safe to use. Our user centred approach balances technical performance with human factors, regulatory requirements and practical constraints, reducing the risk of error and supporting confident adoption in real world clinical settings.

Packaging and transportation

Our nuclear medicine experts help you design and develop compliant Type A packaging for the transportation of radioactive sources (IAEA SSR-6). With experience designing radiation shielding and transport systems for high-activity radiopharmaceuticals, we understand the need to combine safety and ergonomics with regulatory requirements, to ensure your therapies move efficiently through tightly timed clinical pathways.

Working closely with radiopharmaceutical stakeholders and representative users, we immerse ourselves in your product journey, helping you create efficient usability and handling workflows that reduce exposure risk while maintaining efficient throughput.

Generation and purification

We help you solve the complex engineering challenges behind radionuclide generation and purification by delivering robust, user centred equipment that performs reliably in demanding clinical and manufacturing settings. From equipment design, radiation shielding and automation to the integration of off the shelf equipment, we create solutions that are safe, intuitive and designed for dual regulation across pharmaceutical and radiation safety requirements.

Our experience spans full turnkey development of radionuclide generators, automation equipment and optimisation of beta and gamma detection systems, as well as support for brachytherapy devices. By combining applied science with rigorous engineering, we help you reduce technical risk while accelerating your development.

Quality control and dose symmetry

Integrating analytical technologies directly into your development process allows you to achieve reliable quality control and consistent dose symmetry in your nuclear medicine product. Our team applies modelling, data driven insight and pragmatic assay integration to help you understand variability, validate performance and detect issues early.

By embedding fit for purpose analytical tools into your equipment and workflows, we enable faster, more confident decision making and robust batch to batch consistency. Whether you need rapid quality control (QC) workflows, automated analytical checks or evidence based dose verification, we help you de risk development and deliver safe, predictable and commercially ready nuclear medicine solutions.

Analytics and modelling

Advanced analytics and modelling give you early, quantitative insight into complex nuclear medicine systems, enabling more confident technical and commercial decisions in your programme. By modelling concentrations and activities across complex decay chains, we help you gain a clearer understanding of dose behaviour, variability and uncertainty, reducing assumptions and helping you avoid costly changes in late-stage development.

Drawing on these insights, we help you create safer, more efficient system design. This includes analysing radiation emissions and absorption to optimise shielding and design, as well as radiation pulse shape modelling to develop type specific radiation detection algorithms. Together, this evidence base allows you to reduces technical risk, strengthen design justification and accelerate the delivery of reliable, high performance nuclear medicine technologies.

Shielding and safety therapeutics

With in-house radiation labs and experience in developing nuclear medicine systems that meet regulatory standards for shielding and safety, we ensure your technology protects your users while remaining practical and efficient to operate.

Our team designs equipment that complies with cGMP and nuclear industry regulations, supporting you from early concept through verification. Using analytical and mathematical modelling, we identify risk, define shielding requirements and validate safety critical decisions long before hardware is built. Whether you need robust containment, safe workflow integration or evidence based design justification, we help you de risk your development and create reliable, regulation ready systems that stand up to real world clinical and manufacturing demands.

IMG_8099 edit

On site radiation lab facilities

Our on site radiation lab gives you immediate access to specialised infrastructure designed to accelerate nuclear medicine development. The lab is fully equipped, operates under validated safety protocols and risk assessments, and has been independently confirmed as compliant by a certified Radiation Protection Advisor (RPA). We are adept at rapid turnaround times, with established suppliers and a license to store and work with low-activity sealed sources of Beta and Gamma radiation.

With an in-house team of skilled personnel, including an appointed Radiation Protection Supervisor (RPS) and engineers experienced in handling radiation sources, we build reliability and established processes into your development from day one. Supported by trusted partners supplying Tungsten, Lead (Pb) components and rapid prototyping capability, we provide a dependable environment to safely test, refine and validate your nuclear medicine technology.

IMG_2511

Life cycle management

Whether you’re refining an on market system or preparing a next generation update, we focus on maximising the long term performance and commercial value of your nuclear medicine products through targeted life cycle management.

Our engineering and human factors teams identify inefficiencies, simplify user interactions and help you minimise ongoing operational costs. By applying rigorous analysis, iterative testing and evidence based design improvements, we support you in extending your product’s lifetime and ensuring your technology continues to meet evolving clinical and regulatory expectations.

EG7A8493

Regulatory support

Navigating regulatory expectations in nuclear medicine can be complex. Requirements for radiopharmaceutical manufacturing vary widely across regions, with US radiopharmacies operating under USP 797 and 825 at a state level, alongside ongoing legal grey areas and shifting expectations. European markets such as the UK, France and the Netherlands each impose different GMP requirements, and many US facilities are already transitioning to GMP to stay ahead of tightening regulations.

We help you find the right balance between manual and automated compounding. This is essential when radiation levels make manual dose preparation unsafe, while the cost of fully automated synthesis may be difficult to justify. We also support you in managing the significant regulatory workload, including activities such as QP release, so your development and manufacturing processes remain safe, auditable, and commercially viable.

Meet our nuclear medicine and medical imaging experts

Kate Hudson-Farmer

Kate Hudson-Farmer - Director, Advanced MedTech

As Director, Advanced Medtech, Kate leads Team Consulting’s strategic growth across some of the most rapidly evolving, progressive and complex areas of healthcare innovation. She is responsible for building and expanding Team’s advanced MedTech offering, supporting clients as they navigate the technical, clinical and commercial challenges involved in next generation health technologies.

Explore

Kate Hudson-Farmer - Director, Advanced MedTech
Joseph Conroy

Joe Conroy - Senior Consultant, Advanced MedTech

As a Senior Consultant – Advanced MedTech, Joseph leads medical device development programmes, with a specialist focus on advanced medtech including radiopharmaceuticals, radiology and nuclear medicine. He brings a combination of translational insight and commercialisation expertise, helping Team Consulting’s clients turn early‑stage technical ideas into robust, scalable and commercially viable products.

Explore

Joe Conroy - Senior Consultant, Advanced MedTech

Looking to bring your nuclear medicine solution to market?

Whether you are looking to develop a theranostic solution or a next-generation radiology system, we help you create nuclear medicine technologies that transform healthcare. Find out how we can solve your challenges today.